pearson correlation using graphpad prism v.6 Search Results


90
GraphPad Software Inc pearson correlation using graphpad prism v.6
Pearson Correlation Using Graphpad Prism V.6, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pearson+correlation+using+graphpad+prism+v%2E6/pmc07898322-67-42-44?v=GraphPad+Software+Inc
Average 90 stars, based on 1 article reviews
pearson correlation using graphpad prism v.6 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc pearson’s correlation test graphpad prism v.6.0f
Chemotatic pathways involving CCL5 and CXCL16 induced by Yttrium-90 (Y90)-radioemboli s ation (RE). (A) Reactome pathway analysis showed CXCL16-CXCR6 and CCL5-CCR5 chemotaxis pathways indicated by enriched genes in post-Y90-RE tumours. Boxes indicate protein complexes while circles indicated individual molecule/proteins. Yellow indicates involvement of enriched genes identified by our next-generation sequencing data. (B) RNA expression of CCL5 and CXCL16 in Y90-treated (n=8) vs control (Ctl) (n=6) tumour tissues by quantitative PCR analysis. (C) Correlation between RNA expression of CCL5 and CXCL16 and the percentage of tumour-infiltrating GB + CD8 + -activated T cells (n=14). Graphical data represent the means±SD. P values and correlation coefficients (r) were calculated using the <t>Pearson’s</t> correlation test. *P<0.05 and **P<0.01.
Pearson’s Correlation Test Graphpad Prism V.6.0f, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pearson+correlation+using+graphpad+prism+v%2E6/pmc06352403-75-11-14?v=GraphPad+Software+Inc
Average 90 stars, based on 1 article reviews
pearson’s correlation test graphpad prism v.6.0f - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Chemotatic pathways involving CCL5 and CXCL16 induced by Yttrium-90 (Y90)-radioemboli s ation (RE). (A) Reactome pathway analysis showed CXCL16-CXCR6 and CCL5-CCR5 chemotaxis pathways indicated by enriched genes in post-Y90-RE tumours. Boxes indicate protein complexes while circles indicated individual molecule/proteins. Yellow indicates involvement of enriched genes identified by our next-generation sequencing data. (B) RNA expression of CCL5 and CXCL16 in Y90-treated (n=8) vs control (Ctl) (n=6) tumour tissues by quantitative PCR analysis. (C) Correlation between RNA expression of CCL5 and CXCL16 and the percentage of tumour-infiltrating GB + CD8 + -activated T cells (n=14). Graphical data represent the means±SD. P values and correlation coefficients (r) were calculated using the Pearson’s correlation test. *P<0.05 and **P<0.01.

Journal: Gut

Article Title: Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma

doi: 10.1136/gutjnl-2017-315485

Figure Lengend Snippet: Chemotatic pathways involving CCL5 and CXCL16 induced by Yttrium-90 (Y90)-radioemboli s ation (RE). (A) Reactome pathway analysis showed CXCL16-CXCR6 and CCL5-CCR5 chemotaxis pathways indicated by enriched genes in post-Y90-RE tumours. Boxes indicate protein complexes while circles indicated individual molecule/proteins. Yellow indicates involvement of enriched genes identified by our next-generation sequencing data. (B) RNA expression of CCL5 and CXCL16 in Y90-treated (n=8) vs control (Ctl) (n=6) tumour tissues by quantitative PCR analysis. (C) Correlation between RNA expression of CCL5 and CXCL16 and the percentage of tumour-infiltrating GB + CD8 + -activated T cells (n=14). Graphical data represent the means±SD. P values and correlation coefficients (r) were calculated using the Pearson’s correlation test. *P<0.05 and **P<0.01.

Article Snippet: A paired or unpaired Student’s t-test or Mann-Whitney U test and Pearson’s correlation test (GraphPad Prism V.6.0f) was used to analyse the FlowJo and qPCR data, as indicated.

Techniques: Chemotaxis Assay, Next-Generation Sequencing, RNA Expression, Control, Real-time Polymerase Chain Reaction